Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase Ib / II Trial Evaluating the Association Myocet ® - Carboplatine in Patients Having a Cancer of the Ovary in Relapse, Sensitive to the Platinum

NCT01705158 is registered in ClinicalTrials.gov with ARCAGY/ GINECO GROUP as lead sponsor.

NCT NCT01705158
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01705158 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase Ib / II Trial Evaluating the Association Myocet ® - Carboplatine in Patients Having a Cancer of the Ovary in Relapse, Sensitive to the Platinum
Lead sponsor
ARCAGY/ GINECO GROUP
Phase
Phase 1/2
Overall status
Completed
Start date
October 31, 2012
Completion date
April 30, 2017
Enrollment
87 (actual)
Sites
42

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian cancer